Skip to main content
Caplight Logo









Neuroblox

Neuroblox

Private
Stony Brook, New YorkHealthcare & Life Scienceshttps://www.neuroblox.ai/

Last Round

Accelerator

Feb 24, 2025

Total Funding Raised

$3.2M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Neuroblox is a biotechnology and software company that provides a multiscale, mechanistic neural circuit simulation platform for designing and testing neurotherapeutics in silico.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Healthcare Analytics, Precision Medicine

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Freemium

AI Layer

Application

Keywords

neural circuit simulationcomputational neurosciencein silico drug developmentbrain simulation softwaremechanistic modelingbrain digital twinneurotherapeuticsscientific machine learningin silico clinical trialsmultiscale modelingAI drug discoverypre-clinical validationin silico experimentationneuroCADsimulation-based inference

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Neuroblox Comparables

Compare Neuroblox with similar companies based on industry and business-model similarity.

Neuroblox comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Forecast Bio, Inc.
81%
InSilicoTrials Technologies
77%
NeuroX1
75%

Neuroblox Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorFeb 24, 2025
GrantMay 8, 2023

Key People

Founding team and executive leadership

Lilianne Mujica-Parodi

Chief Executive Officer

Executive Team

Neuroblox Investors

Notable investors and investment history

Neuroblox investors
InvestorRounds
Baszucki GroupGrant
One Mind AcceleratorAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 27, 2026

    Monthly visitors increased 1235% MoM.

  • Feb 24, 2025

    Received funding from One Mind Accelerator.

Neuroblox Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Neuroblox Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Neuroblox's valuation, stock price, and market status.

Firmographic Details

HeadquartersStony Brook, New York
Employee Range10
Year Founded2023
Last FundingFeb 24, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?